City

Shanghai (1)

Condition

Double Expressor Lymphoma (1)

Overall Status

Unknown status (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Fudan University (1)

Collaborator

Intervention

lenalidomide combined with r-chop (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

double expressor lymphoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Double Expressor Lymphoma Trial in Shanghai (Lenalidomide combined with R-CHOP)

Unknown status

Double Expressor Lymphoma

Lenalidomide combined with R-CHOP

Shanghai, China

270 Dongan Road, Fudan University Shanghai Cancer Center

Nov 14, 2019